EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.6.1.52 | Adenocarcinoma of Lung |
31988456 |
Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFN? axis. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
2
1
4 |
| 2.6.1.52 | Adenocarcinoma, Mucinous |
22321069 |
Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
1
1
0 |
| 2.6.1.52 | Brain Diseases |
26610677 |
Two new cases of serine deficiency disorders treated with l-serine. |
causal interaction
unassigned |
4
0 |
| 2.6.1.52 | Breast Neoplasms |
15899800 |
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
1
2 |
| 2.6.1.52 | Breast Neoplasms |
24390667 |
Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.6.1.52 | Breast Neoplasms |
27326252 |
Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.6.1.52 | Breast Neoplasms |
28522855 |
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
1
4
0 |
| 2.6.1.52 | Breast Neoplasms |
29661856 |
Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells. |
unassigned |
0 |
| 2.6.1.52 | Breast Neoplasms |
31630284 |
Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 2.6.1.52 | Carcinogenesis |
27372650 |
Overexpression of Phosphoserine Aminotransferase 1 (PSAT1) Predicts Poor Prognosis and Associates with Tumor Progression in Human Esophageal Squamous Cell Carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
